You're using an outdated browser. This website will not display correctly and some features will not work.
Learn more about the browsers we support for a faster and safer online experience.

contact us français

Welcome to the new e-Laws. It’s now easier than ever to find Ontario laws. We welcome your feedback.

Important: This version of the e-Laws website will be upgraded to a new version in the coming weeks.
You can try the beta version of the new e-Laws at ontario.ca/laws-beta.

O. Reg. 460/22: GENERAL

filed May 3, 2022 under Pharmacy Act, 1991, S.O. 1991, c. 36

Skip to content
Print Download

 

ontario regulation 460/22

made under the

Pharmacy Act, 1991

Made: April 25, 2022
Approved: April 28, 2022
Filed: May 3, 2022
Published on e-Laws: May 3, 2022
Printed in The Ontario Gazette: May 21, 2022

Amending O. Reg. 202/94

(GENERAL)

1. (1) Subsection 35 (1) of Ontario Regulation 202/94 is revoked and the following substituted:

(1) For the purposes of paragraph 3 of subsection 4 (1) of the Act, a member referred to in subsection (3) who complies with the other requirements of this section is authorized to prescribe the following drugs:

1. For the sole purpose of smoking cessation, the following specified drugs:

i. Varenicline Tartrate.

ii. Bupropion Hydrochloride.

2. For the sole purpose of treating a minor ailment listed in Column 1 of the Table to Schedule 4, a drug in a class of drugs listed opposite the minor ailment in Column 2 of that Table.

(2) Subsection 35 (2) of the Regulation is revoked.

(3) Subsection 35 (4) of the Regulation is amended by striking out “and” at the end of clause (e), by adding “and” at the end of clause (f) and by adding the following clause:

(g) in the case of a drug referred to in paragraph 2 of subsection (1), has determined, through a therapeutic assessment, that the drug is the most appropriate treatment for the patient’s minor ailment.

2. Paragraph 2 of section 38 of the Regulation is amended by adding “clause 35 (4) (d) or” before “paragraph 4 of subsection 36 (4)”.

3. The Regulation is amended by adding the following Schedule:

Schedule 4
DrugS — Minor Ailments

(Arranged by American Hospital Formulary Service (AHFS) Pharmacologic-Therapeutic Classification)

Item

Column 1
Minor Ailment

Column 2
AHFS Classification

1.

Allergic rhinitis

4:08
Second Generation Antihistamines
52:02
Eye, Ear, Nose and Throat (EENT) Preparations — Antiallergic Agents
52:08.08
Eye, Ear, Nose and Throat (EENT) Preparations — Anti-inflammatory Agents — Corticosteroids

2.

Candidal stomatitis

8:14.28
Anti-infectives — Antifungals — Polyenes

3.

Conjunctivitis (bacterial, allergic or viral)

04:04.20
Propylamine Derivatives
52:32
Eye, Ear, Nose and Throat (EENT) Preparations — Vasoconstrictors
52:04.04
Eye, Ear, Nose and Throat (EENT) Preparations — Anti-infectives — Antibacterials
52:02
Eye, Ear, Nose and Throat (EENT) Preparations — Antiallergic Agents

4.

Dermatitis (atopic/eczema, allergic or contact)

84:06 Skin and Mucous Membrane Agents — Anti-inflammatory Agents

5.

Dysmenorrhea

28:08.04
Central Nervous System Agents — Analgesics and Antipyretics — Nonsteroidal Anti-inflammatory Agents

6.

Gastroesophageal reflux disease (GERD)

56:04
Gastrointestinal Drugs — Antacids and Adsorbents
56:28.12
Gastrointestinal Drugs — Antiulcer Agents and Acid Suppressants — Histamine H2-Antagonists
56:28.36
Gastrointestinal Drugs — Antinuclear Agents and Acid Suppressants — Proton-Pump Inhibitors

7.

Hemorrhoids

12:12.04
Autonomic Drugs — Sympathomimetic (Adrenergic) Agents — Alpha-Adrenergic Agonists
52:04.92
Eye, Ear, Nose and Throat (EENT) Anti-infectives — Miscellaneous
84:06
Skin and Mucous Membrane Agents — Anti-inflammatory Agents
84:08
Skin and Mucous Membrane Agents — Antipruritics and Local Anesthetics
84:04.04
Skin and Mucous Membrane Agents — Anti-infectives — Antibacterials

8.

Herpes labialis

8:18.32
Anti-infective Agents — Antivirals — Nucleosides and Nucleotides
84:06
Skin and Mucous Member Agents — Anti-inflammatory Agents
84:04.06
Skin and Mucous Membrane Agents — Anti-infectives — Antivirals

9.

Impetigo

84:04.04
Skin and Mucous Membrane Agents — Anti-infectives — Antibacterials
84:06
Skin and Mucous Member Agents - Anti-inflammatory Agents

10.

Insect bites and urticaria

4:04
Antihistamine Drugs — First Generation Antihistamines
4:08
Antihistamine Drugs — Second Generation Antihistamines
84:06
Skin and Mucous Member Agents — Anti-inflammatory Agents
84:08
Skin and Mucous Membrane Agents — Antipruritics and Local Anesthetics

11.

Tick bites, post-exposure prophylaxis to prevent Lyme disease

8.12.24
Anti-infective Agents — Antibacterials — Tetracyclines

12.

Musculoskeletal sprains and strains

28:08.04
Central Nervous System Agents — Analgesics and Antipyretics — Nonsteroidal Anti-inflammatory Agents
28.08.92
Central Nervous System Agents — Analgesics and Antipyretics — Miscellaneous

13.

Urinary Tract Infection (uncomplicated)

8:12.20
Anti-infective Agents — Antibacterials — Sulfonamides
8:36
Anti-infective Agents — Urinary Anti-infectives

 

Commencement

4. This Regulation comes into force on the later of January 1, 2023 and the day this Regulation is filed.

Made by:

Council of the Ontario College of Pharmacists:

Billy Cheung

Chair, OCP Board

Susan James

Acting Registrar, Director Quality

Date made: April 25, 2022